FGF19 (fibroblast growth factor 19) as a novel target gene for activating transcription factor 4 in response to endoplasmic reticulum stress

Biochemical Journal

Volumn 450, Issue 1, 2013, Pages 221-229

  Shimizu, Makoto ^a   Li, Juan ^a   Maruyama, Ryuto ^a   Inoue, Jun ^a   Sato, Ryuichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Activating transcription factor 4 (ATF4); Endoplasmic reticulum stress (ER stress); Farnesoid X receptor (FXR); Fibroblast growth factor 15 (FGF15); Fibroblast growth factor 19 (FGF19); Intestine

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALCIMYCIN; DITHIOTHREITOL; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR 19; MESSENGER RNA; SHORT HAIRPIN RNA; THAPSIGARGIN; TUNICAMYCIN;

5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN CACO 2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN SECRETION;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; CACO-2 CELLS; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; MICE; MICE, INBRED BALB C; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84873047162     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20121393     Document Type: Article

References (37)

1. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A. et al. (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217-225
2. Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K. F., Donahee, M., Wang, D. Y., Mansfield, T. A., Kliewer, S. A. et al. (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17, 1581-1591
3. Choi, M., Moschetta, A., Bookout, A. L., Peng, L., Umetani, M., Holmstrom, S. R., Suino-Powell, K., Xu, H. E., Richardson, J. A., Gerard, R. D. et al. (2006) Identification of a hormonal basis for gallbladder filling. Nat. Med. 12, 1253-1255
4. Potthoff, M. J., Boney-Montoya, J., Choi, M., He, T., Sunny, N. E., Satapati, S., Suino-Powell, K., Xu, H. E., Gerard, R. D., Finck, B. N. et al. (2011) FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. Cell Metab. 13, 729-738
5. Kir, S., Beddow, S. A., Samuel, V. T., Miller, P., Previs, S. F., Suino-Powell, K., Xu, H. E., Shulman, G. I., Kliewer, S. A. and Mangelsdorf, D. J. (2011) FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331, 1621-1624
6. Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D. and Stewart, T. A. (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143, 1741-1747
7. Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M., Williams, P. M., Soriano, R., Corpuz, R., Moffat, B. et al. (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145, 2594-2603
8. Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G. and Gonzalez, F. J. (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102, 731-744
9. Sever, N., Song, B. L., Yabe, D., Goldstein, J. L., Brown, M. S. and DeBose-Boyd, R. A. (2003) Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J. Biol. Chem. 278, 52479-52490
10. Das, S. K., Chu, W. S., Mondal, A. K., Sharma, N. K., Kern, P. A., Rasouli, N. and Elbein, S. C. (2008) Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines. Am. J. Physiol. Endocrinol. Metab. 295, E393-E400
11. Ohmachi, T., Inoue, H., Mimori, K., Tanaka, F., Sasaki, A., Kanda, T., Fujii, H., Yanaga, K. and Mori, M. (2006) Fatty acid binding protein 6 is overexpressed in colorectal cancer. Clin. Cancer Res. 12, 5090-5095
12. Okuwaki, M., Takada, T., Iwayanagi, Y., Koh, S., Kariya, Y., Fujii, H. and Suzuki, H. (2007) LXRα transactivates mouse organic solute transporter α and β via IR-1 elements shared with FXR. Pharm. Res. 24, 390-398
13. Jeong, Y., Xie, Y., Xiao, G., Behrens, C., Girard, L., Wistuba, I. I., Minna, J. D. and Mangelsdorf, D. J. (2010) Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med. 7, e1000378
14. Inoue, J., Yamasaki, K., Ikeuchi, E., Satoh, S., Fujiwara, Y., Nishimaki-Mogami, T., Shimizu, M. and Sato, R. (2011) Identification of MIG12 as a mediator for stimulation of lipogenesis by LXR activation. Mol. Endocrinol. 25, 995-1005
15. Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P. and Foufelle, F. (2009) GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119, 1201-1215
16. Rutkowski, D. T., Arnold, S. M., Miller, C. N., Wu, J., Li, J., Gunnison, K. M., Mori, K., Sadighi Akha, A. A., Raden, D. and Kaufman, R. J. (2006) Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol. 4, e374
17. Zhang, Y., Yin, L., Anderson, J., Ma, H., Gonzalez, F. J., Willson, T. M. and Edwards, P. A. (2010) Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia. J. Biol. Chem. 285, 3035-3043
18. Sato, R., Miyamoto, W., Inoue, J., Terada, T., Imanaka, T. and Maeda, M. (1999) Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J. Biol. Chem. 274, 24714-24720
19. Inoue, J., Ito, Y., Shimada, S., Satoh, S. I., Sasaki, T., Hashidume, T., Kamoshida, Y., Shimizu, M. and Sato, R. (2011) Glutamine stimulates the gene expression and processing of sterol regulatory element binding proteins, thereby increasing the expression of their target genes. FEBS J. 278, 2739-2750
20. Eizirik, D. L., Cardozo, A. K. and Cnop, M. (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 29, 42-61
21. Hai, T. and Hartman, M. G. (2001) The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273, 1-11
22. Schröder, M. and Kaufman, R. J. (2005) The mammalian unfolded protein response. Annu. Rev. Biochem. 74, 739-789
23. Harding, H. P., Calfon, M., Urano, F., Novoa, I. and Ron, D. (2002) Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 18, 575-599
24. Ameri, K. and Harris, A. L. (2008) Activating transcription factor 4. Int. J. Biochem. Cell Biol. 40, 14-21
25. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A. H., Iwakoshi, N. N., Ozdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H. and Hotamisligil, G. S. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461
26. Boden, G., Duan, X., Homko, C., Molina, E. J., Song, W., Perez, O., Cheung, P. and Merali, S. (2008) Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 57, 2438-2444
27. Sharma, N. K., Das, S. K., Mondal, A. K., Hackney, O. G., Chu, W. S., Kern, P. A., Rasouli, N., Spencer, H. J., Yao-Borengasser, A. and Elbein, S. C. (2008) Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J. Clin. Endocrinol. Metab. 93, 4532-4541
28. Gregor, M. F., Yang, L., Fabbrini, E., Mohammed, B. S., Eagon, J. C., Hotamisligil, G. S. and Klein, S. (2009) Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 58, 693-700
29. Goetz, R., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C., Neubert, T. A., Zhang, F., Linhardt, R. J. et al. (2007) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 27, 3417-3428
30. Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K. and Yamashita, T. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561-568
31. Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., Fujita, T., Nakahara, K., Fukumoto, S. and Yamashita, T. (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429-435
32. 3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G1036-G1042
33. Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V. et al. (2007) Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415-425
34. Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S. and Maratos-Flier, E. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426-437
35. Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M. and Kuro-o, M. (2007) βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. U.S.A. 104, 7432-7437
36. Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A. et al. (2005) FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635
37. De Sousa-Coelho, A. L., Marrero, P. F. and Haro, D. (2012) Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation. Biochem. J. 443, 165-171